Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Revenue (2022 - 2023)

Historic Revenue for Pasithea Therapeutics (KTTA) over the last 2 years, with Q2 2023 value amounting to $347808.0.

  • Pasithea Therapeutics' Revenue rose 246098.96% to $347808.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $347808.0, marking a year-over-year decrease of 1583.7%. This contributed to the annual value of $486559.0 for FY2022, which is 313037.45% up from last year.
  • As of Q2 2023, Pasithea Therapeutics' Revenue stood at $347808.0, which was up 246098.96% from -$59646.0 recorded in Q1 2023.
  • Pasithea Therapeutics' 5-year Revenue high stood at $347808.0 for Q2 2023, and its period low was -$59646.0 during Q1 2023.